Global 4D Bioprinting Market Predicted to Reach $0.34 Billion, Expanding at 29.8% CAGR Through 2029
Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics
How Does the Market Size of the 4D Bioprinting Market in 2029 Compare With That of 2025?
The 4D bioprinting market size has grown exponentially in recent years. It will grow from $0.09 billion in 2024 to $0.12 billion in 2025 at a compound annual growth rate (CAGR) of 29.4%. The growth in the historic period can be attributed to rise in geriatric population, increasing healthcare expenditure, rise in 3D bioprinting startups, increasing investments in R&D, growing prevalence of chronic diseases.
The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.34 billion in 2029 at a compound annual growth rate (CAGR) of 29.8%. The growth in the forecast period can be attributed to increasing demand for organ transplant, rising aging population, increasing prevalence of chronic diseases, increasing healthcare expenditure, rising demand for personalized medicine. Major trends in the forecast period include technological advancements, collaborations between academia and industry, integration of artificial intelligence, shift towards decentralized manufacturing, integration with 3D imaging technologies.
Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14235&type=smp
Which Key Dynamics Are Contributing to the Expansion of the 4D Bioprinting Market?
The increasing demand for organ transplants is expected to propel the growth of the 4D bioprinting market going forward. Organ transplants involve surgically removing an organ or tissue from one person (the donor) and placing it in another person (the recipient) who needs that organ due to organ failure or dysfunction. The demand for organ transplants arises from the critical need to save lives and improve the quality of life for individuals suffering from organ failure or dysfunction. Organ transplants use 4D bioprinting to advance regenerative medicine by precisely fabricating complex tissues and organs with functional capabilities, offering hope for addressing the shortage of donor organs and improving transplant outcomes. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based government organization, in 2023, a total of 46,632 organ transplants were conducted using both living and deceased donors. This marks an 8.7% rise compared to 2022 and a 12.7% increase from 2021. Therefore, the increasing demand for organ transplants is driving the growth of the 4D bioprinting market.
Which Key Segments Are Included in the 4D Bioprinting Market Analysis?
The 4D bioprintingmarket covered in this report is segmented –
1) By Type Of Technology: Extrusion-Based Technology, Laser-Based Technology, Inkjet-Based Technology, Other Types
2) By Application Area: Biomedical Application, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research And Development, Other End-Users
Subsegments:
1) By Extrusion-Based Technology: FDM (Fused Deposition Modeling), Direct Ink Writing (DIW)
2) By Laser-Based Technology: Laser-Induced Forward Transfer (LIFT), Two-Photon Polymerization
3) By Inkjet-Based Technology: Thermal Inkjet, Piezoelectric Inkjet
4) By Other Types: Stereolithography (SLA), Digital Light Processing (DLP)
What Are the Current Trends Influencing the 4D Bioprinting Market?
Major companies operating in the 4D bioprinting market are forming strategic partnerships to enhance their technological capabilities and accelerate the development of innovative solutions in tissue engineering and regenerative medicine. These companies are also collaborating to foster innovation and expand their research and development efforts. For instance, in March 2024, Poietis, a France-based biotechnology that provides 4D laser bioprinting partnered with HVD Life Science company. With this partnership, Poietis aims to promote the Next Generation Bioprinting (NGB-R) platform in Germany and enhance access to advanced bioprinting technology for researchers in the fields of tissue engineering, regenerative medicine, and drug discovery. HVD Life Science is an Austria-based marketing and distribution company specialized in life science solutions.
Who Are the Key Strategic Players in the 4D Bioprinting Market Ecosystem?
Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.
Get the detailed 4d bioprinting market report today
https://www.thebusinessresearchcompany.com/report/4d-bioprinting-global-market-report
What Are the Fastest-Growing Regions in the 4D Bioprinting Market?
North America was the largest region in the 4D bioprinting market in 2024. The regions covered in the 4D bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: Market Research Reports
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment